Advanced company searchLink opens in new window

CAPELLA BIOSCIENCE LTD

Company number 09301325

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
23 Nov 2021 SH08 Change of share class name or designation
02 Nov 2021 MA Memorandum and Articles of Association
02 Nov 2021 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of alteration of Articles of Association
29 Oct 2021 RESOLUTIONS Resolutions
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
29 Oct 2021 MA Memorandum and Articles of Association
21 Oct 2021 AA Accounts for a small company made up to 31 December 2020
21 Oct 2021 MR01 Registration of charge 093013250003, created on 4 October 2021
20 Oct 2021 MR01 Registration of charge 093013250002, created on 1 October 2021
14 Oct 2021 MR01 Registration of charge 093013250001, created on 4 October 2021
12 Jul 2021 PSC05 Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 14 May 2021
08 Jul 2021 PSC05 Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 4 May 2021
08 Jul 2021 PSC05 Change of details for United Medicines Biopharma Limited as a person with significant control on 17 February 2021
01 Jun 2021 AD01 Registered office address changed from 158-160 North Gower Street London NW1 2nd to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT on 1 June 2021
12 Feb 2021 SH01 Statement of capital following an allotment of shares on 29 January 2021
  • GBP 11,305.994
12 Feb 2021 AP01 Appointment of Marella Thorell as a director on 29 January 2021
12 Feb 2021 AP01 Appointment of Mr Iqbal Hussain as a director on 29 January 2021
12 Feb 2021 AP01 Appointment of Dr Saurabh Saha as a director on 29 January 2021
12 Feb 2021 TM01 Termination of appointment of Kevin Stuart Johnson as a director on 29 January 2021
12 Feb 2021 TM01 Termination of appointment of Rajesh Bhikhu Parekh as a director on 29 January 2021
12 Feb 2021 TM01 Termination of appointment of Steve Holmes as a director on 29 January 2021
12 Feb 2021 PSC02 Notification of United Medicines Biopharma Limited as a person with significant control on 29 January 2021
12 Feb 2021 PSC07 Cessation of Advent Life Sciences Llp as a person with significant control on 29 January 2021
07 Dec 2020 AA Accounts for a small company made up to 31 December 2019
29 Oct 2020 CS01 Confirmation statement made on 29 October 2020 with updates
28 Oct 2020 SH01 Statement of capital following an allotment of shares on 21 October 2020
  • GBP 10,824.027